JACQUELINE CAREY: Open Payments
NPI 1215572672 · SOMERS POINT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 34 payments from 12 companies in 2025. Trend: 2023 $963 · 2024 $1,681 · 2025 $791
Food & beverage: $681Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $248 |
| Janssen Biotech, Inc. | 9 | $224 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $114 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
| LEO Pharma Inc. | 2 | $31 |
| GENZYME CORPORATION | 1 | $18 |
| STRATA Skin Sciences, Inc. | 2 | $18 |
| Biofrontera Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: SKYRIZI, TREMFYA, ILUMYA, DUPIXENT, ADBRY, XTRAC, LIBTAYO, SPEVIGO.
Industry payments across NJ — which companies pay providers there.
